Oct 27, 2021 7:00am EDT Recro Enters Into Master Commercial Supply and Services Agreement With Otsuka
Oct 20, 2021 7:00am EDT Recro Awarded Development and Manufacturing Contract by National Institutes of Health (NIH) to Support Novel Nasal Spray Analgesic
Sep 08, 2021 7:00am EDT Recro and BioCorRx Expand Development and Manufacturing Relationship to Support BICX104, an Implantable Naltrexone Pellet for the Treatment of Opioid Use Disorder